Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

Name: Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL
Creator: Victoria P. Werth
Published: 2024-09-19T21:21:24.381Z
Keywords: Systemic Lupus Erythematosus, Lupus Erythematosus

Werth, Victoria P.; Merrill, Joan T.; Furie, Richard; Dörner, Thomas; van Vollenhoven, Ronald; Lipsky, Peter; Weiswasser, Michael; Korish, Shimon; Schafer, Peter H.; Stern, Mark; Li, Stan; Delev, Nikolay

doi:10.17632/pfsydwvcj2.1

Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

Published: 19 September 2024| Version 1 | DOI: 10.17632/pfsydwvcj2.1

Contributors:

Victoria P. Werth, Joan T. Merrill, Richard Furie, Thomas Dörner, Ronald van Vollenhoven, Peter Lipsky, Michael Weiswasser, Shimon Korish, Peter H. Schafer, Mark Stern, Stan Li, Nikolay Delev

Description

Supplementary materials for the Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial manuscript.

Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

Description

Files

Institutions

Categories

Funding

Licence